Integra LifeSciences | IART - Gross Profit On Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Integra LifeSciences

Integra LifeSciences reported $238.94M in Gross Profit on Sales for its fiscal quarter ending in March of 2023.


Gross Profit On Sales Change
Abbott ABT:US USD 5.42B 135M
Baxter International BAX:US USD 1.35B 120M
Becton, Dickinson and Co. BDX:US USD 2.24B 102M
Boston Scientific BSX:US USD 2.34B 101M
CONMED CNMD:US USD 157.42M 25.56M
Cooper Companies COO:US USD 582.9M 24.4M
Dexcom DXCM:US USD 462.6M 92.6M
Edwards Lifesciences EW:US USD 1.13B 39.7M
Globus Medical GMED:US USD 205.86M 1.96M
Hologic HOLX:US USD 585.8M 32.1M
Insulet PODD:US USD 240.5M 23.2M
Integra LifeSciences IART:US USD 238.94M 9.01M
Intuitive Surgical ISRG:US USD 1.11B 2.1M
J&J JNJ:US USD 16.35B 356M
Merit Medical Systems MMSI:US USD 138.36M 3.81M
NuVasive NUVA:US USD 221.34M 6.67M
Smith & Nephew PLC SN/:LN USD 1.85B 21M
Stryker SYK:US USD 3.02B 247M
Tandem Diabetes Care TNDM:US USD 82.91M 32.62M
Teleflex TFX:US USD 391.38M 30.69M
Zimmer Biomet Holdings Inc ZBH:US USD 1.33B 25.4M